Diet and C-reactive protein
- 1 November 2003
- journal article
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 5 (6) , 431-436
- https://doi.org/10.1007/s11883-003-0032-z
Abstract
C-reactive protein (CRP) is an independent predictor of cardiovascular events in healthy individuals and those with pre-existing disease. It also probably contributes to the disease process. CRP levels are higher in obese subjects and this link is almost certainly because of increased insulin resistance. Interventions that alter insulin resistance, such as weight loss, exercise, and conjugated linoleic acid, also alter CRP. Glycemic load is associated with CRP, but there have been no interventions with altered macronutrient composition. In the context of weight loss, macronutrient composition is probably not important. Alcohol lowers CRP, but the mechanism is unknown. The interaction between gender and obesity needs further work, but it appears that obesity has a greater effect on CRP levels in women.Keywords
This publication has 47 references indexed in Scilit:
- C-Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth MuscleCirculation, 2003
- Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-CreeInternational Journal of Obesity, 2003
- C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial CellsCirculation, 2003
- IL-6 and TNF-α expression in, and release from, contracting human skeletal muscleAmerican Journal of Physiology-Endocrinology and Metabolism, 2002
- Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical interventionInternational Journal of Obesity, 2002
- Endothelin Antagonism and Interleukin-6 Inhibition Attenuate the Proatherogenic Effects of C-Reactive ProteinCirculation, 2002
- Modulation of C-Reactive Protein–Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis DrugsCirculation, 2001
- Circulating Interleukin 6 Levels, Blood Pressure, and Insulin Sensitivity in Apparently Healthy Men and WomenJournal of Clinical Endocrinology & Metabolism, 2001
- Down-Regulation of the Acute-Phase Response in Patients with Pancreatic Cancer Cachexia Receiving Oral Eicosapentaenoic Acid is Mediated via Suppression of Interleukin-6Clinical Science, 1997
- Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes.Molecular and Cellular Biology, 1992